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要　旨
本総説において以下の知見を得たのでこれらについて述べる。１　 ）マウスを用いた金線連の薬理活性、
特に肝障害改善作用について検討した。２　 ）ボランテイアによる脂質関連障害の改善傾向を認めた。３　 ）
金線連の粗エキスから脂質代謝改善作用を指標として kinsenoside を単離し、本化合物が活性本体であ
ることを明らかにした。
ラン科に属する金線連（Anoectochilus formosanus Hayata）は台湾から沖縄にかけて自生しており、高
血圧、肺障害、肝障害、小児の発育障害等に用いられてきた。原料の枯渇から金線連の近縁種が代用と
して用いられるようになってきた。かかる現状から研究材料を確保する目的で、金線連の完熟種子を培
地へ無菌的に播種し、発芽後幼植物を得た。このものを液体培地で培養し、植物体を得て実験材料とし
た。
金線連のエキスは四塩化炭素で誘導する肝細胞障害を抑制することが判明した。また、マウスの体重
増加や肝重量増加を抑制した。さらにマウスの肝臓や血清中の脂質を低下させる作用が認められた。ボ
ランテイアによる金線連エキスの臨床試験の結果、健常者には作用しないが、脂質やコレステロール、
またその両者が高い患者に対しては VLDL や LDL、ALT、AST 値を下げることが明らかとなった。
培養金線連を抽出しカラムクロマトにて成分の精製単離を行い、８　 種の化合物を単離し構造を明らか
にした。その中で量的にも多い kinsenoside についてはＸ線解析を行い、絶対構造を明らかにした。
金線連エキスにつき脂質代謝を指標として分画を行い、kinsenoside がその活性本体であることを明
らかにした。Kinsenoside を金線連エキス同様の評価系にて評価した結果、肝臓や子宮の脂質量低下作
用があることが明らかとなった。脂肪肝を発症させたマウスに kinsenoside を与えて顕微鏡により調査
した結果、０.２％の kinsenoside を与えることにより脂肪肝は改善されることが明らかとなった。
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Abstract
In this review we discuss the pharmacological activities of Anoectochilus formosanus in mice and 
the clinical evidences using volunteers, and the determination of an active component from A.
formosanus.
The extract of A. formosanus showed significant activity in decreasing the levels of the cytosolic 
enzymes LDH, GOT and GPT, and the result demonstrated that in vitro cultured A. formosanus pos-
sessed prominent hepatoprotective activity against CCl４-induced hepatotoxicity.　In the test using 
aurothioglucose-induced obese mice, the extract of A. formosanus showed a significant antihyperlipo-
sis effect.　The body and liver weights were significantly suppressed ameliorating TG levels in the 
liver and serum in the extract treated group.　When the high TG volunteers were used, the admini-
stration of A. formosanus significantly decreased the levels of TC, VLDL and Apo E.　The results of 
総　　説 
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Introduction
The Anoectochilus species（Orchidaceae）
is perennial herbs which comprise more than 
３５ species that are widespread in the tropical 
regions, from India through the Himalayas 
and  southeast  Asia  to  Hawaii.１） Several 
species have been used in Chinese folk 
medicines.２）　 Among  them,  A.  formosanus 
which is only found in Taiwan and Okinawa, 
has been used for hypertension, lung and 
liver diseases and underdeveloped children as 
a folk medicine.３）It becomes evident that the 
natural resources of A. formosanus are becom-
ing exhausted, therefore the other Anoectochi-
lus species such as A. koshunensis and a 
different genus, Goodyera species are commer-
cialized as substitutes used for the same pur-
pose in the recent market.４，５）From such 
situation we started to investigate the micro-
propagation of this species by tissue culture 
techniques, and worked on its chemical com-
ponents and pharmacological profiles.６８）
Since we isolated a great amount of kin-
senoside without its methyl ester by silica 
gel column chromatography eluting with 
chloroform-ethanol solvent system, it is eas-
ily suggested that some artificial conversion 
occurred during the separation procedure. 
This result inspired us to investigate the ex-
istence and concentrations of kinsenoside 
and its analogues in Anoectochilus species. 
Purified kinsenoside had antihyperliposis 
and hepatoprotective activity.
This review demonstrated the clinical 
evidences using volunteers will be also 
discussed.
１．Micropropagation of A. formosanus and 
its components
The ripened fruits of A. formosanus were 
sterilized, and seeds in fruits were cultured 
on １/２ MS medium９） supplemented with １ 
mg/l ６-benzylaminopurine（BA）and ２ g/l 
peptone.　After ３０ days the seeds germi-
nated and formed protocorms at ２５℃.　The 
seedlings, ６８ cm in length, were transferred 
to １/２ MS liquid medium to produce the mul-
tiple shoot complex.　They were cultured in 
１/２ MS liquid medium supplemented with 
０.３ mg/l BA and ０.０３ mg/l α-naphthalenea-
cetic acid（NAA）under shaking at ３０ rpm.
 After ２ months they were transferred to 
１/２ MS liquid medium without growth regu-
lator and shaken for ４ more months.　The 
regenerated plantlets were grown for ６８ 
months as indicated in Fig.１.　Since the wild 
and cultured A. formosanus had the completely 
same composition, the cultured  plants  were 
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the present study suggest that A. formosanus may be useful for improvement of lipid-metabolism 
and the prevention of atherosclerosis.
A. formosanus grown in wild and propagated by tissue culture contain ten compounds including 
a major known component, kinsenoside and two new components, ３-（R）-３- β-D-glucopy-
ranosyloxy-４-hydroxybutanoic acid, and ２-（β-D-glucopyranosyloxymethyl）-５-hydroxymethyl-
furan, along with the known compounds, １-O-isopropyl- β-D-glucopyranoside, （R）-（＋）-３,４-
dihydroxy-butanoic acid γ-lactone, ４-（β-D-glucopyranosyloxy）benzyl alcohol, （６R,９S）-９-
hydroxy-megastigma-４,７-dien-３-one-９-O- β-D-glucopyranoside, and corchoionoside C.　In an anti-
hyperliposis assay using high-fat diet rats and in aurothioglucose-induced obese mouse, kinseno-
side significantly reduced the weights of body and liver, and also decreased the triglyceride level in 
the liver compared to those of control rats.
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 used  for  further investigations.
The regenerated plants at three differ-
ent stages of culturing :  multiple shoot-
ing,  shoot elongation and  rooting were 
analyzed.　The results suggested that the 
cultured segments, a, b and c and the origi-
nal plant had the same pattern of composi-
tion, although the concentrations were 
somewhat different.　Therefore, it is evi-
dent that micropropagation of this species 
using plant biotechnological technique will 
be available to enable maintenance of this im-
portant crude drug.
２．Antihyperliposis activity of crude ex-
tract of A. formosanus
The hyperlipidemia and obesity follow-
ing customs of livelihood is a major health 
problem in many countries with the escala-
tion of obesity-related disease.　The preva-
lence  is  increasing  even  in  developing 
countries.　This condition is associated with 
increased risk of cardiovascular, cerebrovas-
cular, and type II diabetes.　The magnitude 
of this health problem gives impetus to 
probe effective therapy, especially with natu-
ral crude drugs.
Liver, the key organ of metabolism and 
excretion is continuously and variedly ex-
posed to xenobiotics because of its strategic 
placement in the body.　It is well recognized 
that free radicals are critically involved in 
various pathological conditions such as can-
cer, cardiovascular disorder, arthritis, in-
flammation, and liver diseases. CCl４ is 
biotransformed under the action of cyto-
chrome P４５０ ２E１ to the free radical trichloro-
methyl or peroxyltrichloromethyl.１０）These 
free radicals primarily affect centrolobular 
hepatocytes, binding to cell, nuclear proteins 
and DNA.１１）Therefore, the evaluation of the 
preventive action in liver damage induced by 
CCl４ has been used widely as an indicator of 
the liver protective ability of drugs in gener-
al, even if CCl４ liver injury resembles the 
damage due to acute viral hepatitis.１１）　The 
extract of A. formosanus showed significant 
activity in decreasing the levels of the 
cytosolic enzymes LDH, GOT and GPT as in-
dicated in Table １, and the result demon-
strated that in vitro cultured A. formosanus 
possessed prominent hepatoprotective activ-
ity against CCl４-induced hepatotoxicity.
After a single injection of aurothiogluco-
se, the mice showed a marked increase in 
body weight, and this method has been used 
widely as an indicator of the antihyperlipo-
sis of drugs in general.　In the results of the 
test using aurothioglucose-induced obese 
mice,１２） the extract showed a significant anti-
hyperliposis effect.　There was no signifi-
cant difference in food consumption between 
the normal and control or sample treated 
groups.　This is in agreement with the 
literature.１２）Fig. ２ shows the body weights 
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Fig １.　Flowering of cultured Anoecto-
chilus formosanus Hayata
of normal mice, and of aurothioglucose-in-
duced obese mice that were fed the HCD（as 
control）or the same diet containing ０.５％ of 
the extract of A. formosanus after ８ weeks, 
respectively.　A rapid weight increase was 
observed in the control group, while it was 
significantly suppressed in the extract 
treated group.　The extract suppressed the 
liver weight increases（Fig. ３）, significantly 
ameliorated TG levels in the liver and serum. 
Concentrations of TG in the liver and serum 
were significantly increased in the control 
group compared to the normal group, while 
these were significantly reduced in the ex-
tract of A. formosanus treated group（Fig. ４ 
and ５）.
Concentrations of TCHO in liver and se-
rum in the control group were slightly 
higher than that in the normal group, but in 
the extract treated group, they were lower 
than in the control group although were not 
significantly different from the normal, con-
trol and extract treated groups（data not 
shown）.　No significant differences were 
noted between the normal, control and ex-
tract treated groups in serum levels of GOT 
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##p＜０.０１ significantly different from the normal 
group; **p＜０.０１ significantly different from the 
control group
Fig ２.　Effect of Anoectochilus formosanus crude 
extract on body weight of mice
Table 1.　Hepatoprotective activity of Anoectochilus formosanus  crude extract on
       CCl4-induced cytotoxicity in primary cultured rat hepatocytes  
GPT（units/ml）GOT（units/ml）LDH（units/ml）Dose（μg/ml）Group
 ９.９３ ± ３.０４ ５５.４５ ± １.８５ １８９.７８ ± ６.１８
CCl４（５mM）
１
１０
１００
Normal
Control
Extract
 ９２.５０ ± ２.４８ ４８０.７３ ± １８.７９ １,９１８.６５ ± ４３.９８
 ７７.２０ ± １.８２* ３１４.７１ ± １７.９２* １,６７８.８３ ± ５１.３７*
 ７２.１８ ± ２.９３* ２５０.５３ ± １４.００* １,５４３.６３ ± ９０.１３*
 ５９.９０ ± ５.１６* ２００.２５ ± １７.５８* １,２９４.７５ ± ９９.５８*
Values are presented as means±SEM, n＝４
Significantly different from the control group, *p＜０.０１
##p＜0.01 significantly different from the normal 
group; **p＜0.01 significantly different from the 
control group
Fig ３.　Effect of Anoectochilus formosanus crude 
extract on liver weight of mice
and GPT, but in the extract of A. formosanus 
treated group, the levels were lower than 
that in the control group（data not shown）.
It has been reported that the change of 
the epididymal fat-pads corresponded to the 
total fat tissue in the body.　From these re-
sults, it was believed that the body weight in-
crease was suppressed by the improvement 
of lipid-metabolism, and it is suggested that 
the whole plants of in vitro cultured A. formo-
sanus may be useful for the treatment for 
hyperliposis,  especially  for  fatty  liver. 
Moreover, the improvement of lipid-metabo-
lism might be closely related to the hepato-
protective activity of A. formosanus.
３．Clinical evidences
The higher levels of TC and TG in serum 
than ２２０ mg/dl and １５０ mg/dl, respectively, 
were considered to be hyperlipidemia.　Since 
the VLDL and LDL levels are depend on the 
increases of TC and TG, it is considered that 
the high-TC or TG levels may possibly in-
duce high-lipoprotein.　Cholesterol status 
became to be considered as an important fac-
tor since the correlation has been established 
between the serum cholesterol level and risk 
of coronary heart disease as well as the sever-
ity of atherosclerosis.１３１６）Moreover, the in-
creases of VLDL and LDL levels were also 
observed in the disease of obesity, diabetes 
and nephrosis.
There were no significant differences in 
all anthropometry and serum biochemical 
parameters during ６ months of the admini-
stration period in normal health subjects. 
On the other hand, the level of Apo E de-
creased significantly after １２-months-treat-
ment and that of VLDL did remarkably
（Table ２）.
When the high TG volunteers were used, 
the administration of A. formosanus signifi-
cantly decreased the levels of TC, VLDL and 
Apo E（Table ３）.　The results of the present 
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##p＜0.01 significantly different from the normal 
group; **p＜0.01 significantly different from the 
control group
Fig ４.　Effect of Anoectochilus formosanus crude 
extract on triglyceride level on the liver 
of mice.
##p＜０.０１ significantly different from the normal 
group; **p＜０.０１ significantly different from the 
control group
Fig ５.　Effect of Anoectochilus formosanus crude 
extract on serum triglyceride level in 
mice
study suggest that A. formosanus may be use-
ful for improvement of lipid-metabolism and 
the prevention of atherosclerosis.　On the 
other hand, Nomura et al. confirmed the 
close correlation between hyperlipidemia, 
fatty liver and obesity by the previous inves-
tigation of nosographic study.１７）
The levels of AST and ALT were sig-
nificantly lower after ６-months-treatment, 
these levels, however, return to the original 
values.　In the present study, １１ volunteers 
were high-ALT・AST levels, and they also 
have higher levels of BMI, VLDL and LDL 
compared to those of the normal volunteers. 
The levels of VLDL and Apo E were signifi-
cantly lower after １２-months-treatment, al-
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Table 2.　Effect of Anoectochilus formosanus crude extract on the lipid metabolism
            　 in normal health subjects
２１ volunteers３６ volunteers
１２ months６ months６ months０ months
 ２３.８ ± ３.３ ２３.７ ± ３.１ ２３.９ ± ３.１ ２３.９ ± ３.２BMI（kg/m２）
Percentage body fat（％）
TG（mg/dl）
TC（mg/dl）
HDLC（mg/dl）
LDL（mg/dl）
VLDL（mg/dl）
Apo AI（mg/dl）
Apo B（mg/dl）
Apo E（mg/dl）
AST（IU/l）
ALT（IU/l）
ALP（IU/l）
γGPT（IU/l）
 ２８.２ ± ３.９ ２８.５ ± ４.４ ２９.４ ± ４.１ ２８.１ ± ４.６
 ８０.７ ± ２５.９ ９３.９ ± ２７.０ ９５.７ ± ４１.４ ９０.１ ± ３０.７
 １７８.３ ± ２８.８ １８９.３ ± ２５.３ １８３.７ ± ３３.０ １７７.９ ± ３１.４
 ５４.７ ± １１.９ ６０.２ ± １５.１ ５４.５ ± １０.１ ５８.８ ± １３.２
 １０７.４ ± ２６.９ １０６.３ ± ２１.９ １０９.３ ± ２６.９ １００.１ ± ２６.２
 ８５.８ ± ３６.５** １２９.９ ± ５３.５ １２９.６ ± ６１.８ １２４.９ ± ５６.４
 １４７.１ ± ２７.６ １４８.８ ± ２２.２ １４９.３ ± ２１.８ １４７.６ ± ２０.７
 ９３.５ ± ３６.３ ８５.２ ± １７.０ ７９.９ ± ２１.５ ５８.８ ± １３.２
 ４.２ ± ０.９* ５.１ ± １.４ ５.１ ± １.３ ５.１ ± １.６
 １８.２ ± ６.３ １７.７ ± ６.５ １６.９ ± ６.２ １６.３ ± ５.５
 １８.９ ± １０.３ １９.１ ± １２.２ １８.５ ± １１.７ １７.７ ± １０.５
 １５９.０ ± ５８.８ １６５.２ ± ６３.９ １６０.４ ± ４３.０ １６２.８ ± ５３.２
 ３１.５ ± ３４.０ ２７.５ ± １９.５ ３１.８ ± ３７.６ ３０.８ ± ３４.２
Values ate presented as mean±SD
*p＜０.０５, **p＜０.０１ : significantly different compared to values before treatment
Table 3.　Effect of Anoectochilus formosanus crude extract on the lipid metabolism
　　　　   in high triglyceride subjects
７ volunteers１４ volunteers
１２ months６ months６ months０ months
 ２５.３ ± ２.３ ２５.４ ± １.８ ２５.５ ± ４.４ ２５.６ ± ４.２BMI（kg/m３）
Percentage body fat（％）
TG（mg/dl）
TC（mg/dl）
HDLC（mg/dl）
LDL（mg/dl）
VLDL（mg/dl）
Apo AI（mg/dl）
Apo B（mg/dl）
Apo E（mg/dl）
AST（IU/l）
ALT（IU/l）
ALP（IU/l）
γGPT（IU/l）
 ２６.７ ± ９.２ ２６.７ ± ６.６ ２７.８ ± ８.１ ２６.８ ± ７.２
 １５９.３ ± ３４.７ ２0７.６ ± ３８.１ ２０４.３ ± ４８.２ ２４２.４ ± ７７.６
 ２0２.４ ± ４７.６* ２２３.７ ± ５６.２ ２０３.９ ± ３６.４ ２０８.２ ± ５０.４
 ４７.７ ± １０.２ ４９.９ ± ９.３ ４４.０ ± １１.５ ４５.９ ± １０.５
 １２２.９ ± ４５.３ １３２.２ ± ４８.８ １１９.０ ± ３３.２ １１５.６ ± ４６.０
 １６５.0 ± ３７.４** ３２９.０ ± ７７.７ ３２１.７ ± ８２.７ ３２３.２ ± ８７.３
 １５８.６ ± ３３.６ １４６.１ ± ２１.２ １４０.０ ± ２３.７ １４１.６ ± ２９.０
 ９９.９ ± ５３.９ １０８.１ ± ２９.９ １０２.４ ± ２４.４ １０４.６ ± ２４.６
 ５.８ ± １.２* ７.３ ± ２.０ ６.９ ± １.４ ７.２ ± ２.３
 １９.４ ± ６.５ ２３.４ ± １２.９ ２１.６ ± ６.７ ２４.６ ± １０.６
 ２２.０ ± １０.５ ２７.９ ± ２０.６ ２７.６ ± １８.４ ３１.７ ± １９.５
 ２０３.１ ± ７７.９ １９８.０ ± ５９.８ １９８.３ ± ５４.６ ２０４.２ ± ５０.３
 ５５.４ ± ６１.２ ５６.１ ± ７４.１ ５２.９ ± ４３.１ ６２.１ ± ６５.２
Values are presented as mean±SD
*p＜０.０５, **p＜０.０１ : significantly different compared to values before treatment
though no difference was observed after ６ 
months-treatment（Table ４）.　The level of 
TG was decreased gradually during １２ 
months.
After administration of A. formosanus for 
６ months, the levels of AST and ALT were 
significantly reduced, and after １２ months of 
treatment, the levels of TC, VLDL and LDL 
were also significantly reduced when used 
high TG and TC volunteers（Table ５）.  From 
these results, it was believed that the im-
provement of lipid-metabolism effect of A.
formosanus might be closely related to the im-
provement of liver function.　Liver, the key 
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Table 4.　Effect of Anoectochilus formosanus crude extract on the lipid metabolism
　　　　   in high cholesterol subjects
１１ volunteers
１２ months６ months０ months
 ２５.６ ± ３.０ ２５.６ ± ３.１ ２５.８ ± ２.７BMI（kg/m２）
Percentage body fat（％）
TG（mg/dl）
TC（mg/dl）
HDLC（mg/dl）
LDL（mg/dl）
VLDL（mg/dl）
Apo AI（mg/dl）
Apo B（mg/dl）
Apo E（mg/dl）
AST（IU/l）
ALT（IU/l）
ALP（IU/l）
γGPT（IU/l）
 ２５.４ ± ５.０ ２６.６ ± ５.８ ２５.６ ± ５.３
 １４３.７ ± ５０.３ １６６.６ ± ４６.６ ２２７.０ ± ５４.７
 ２３５.８ ± ２５.７ ２３９.９ ± １８.５ ２４８.５ ± ２４.２
 ５３.１ ± １４.８ ５０.３ ± １３.０ ５３.９ ± l２.５
 １６０.３ ± ３３.８ １５５.２ ± ２４.８ １５６.３ ± ３６.５
 １５０.０ ± ５３.４* ２８２.０ ± １３２.６ ２８９.９ ± １２６.３
 １５６.６ ± ３９.５ １４６.０ ± ２７.１ １５３.２ ± ３１.２
 １２８.０ ± ５６.３ １２０.０ ± ２０.５ １２５.２ ± １４.５
 ５.９ ± １.５* ６.９ ± １.５ ７.２ ± ２.９
 ２４.９ ± ９.５ ２１.３ ± ６.８* ２７.６ ± １０.０
 ３５.６ ± １８.４ ２７.３ ± １４.４* ３５.３ ± １９.６
 ２１１.７ ± ５６.５ ２０７.０ ± ４８.４ ２０８.６ ± ５３.８
 ７８.４ ± ８９.３ ７１.５ ± ６１.８ ８４.９ ± ７１.０
Values are presented as mean±SD
*p＜０.０５, **p＜０.０１ : significantly different compared to values before treatment
Table 5.　Effect of Anoectochilus formosanus crude extract on the lipid metabolism
　　　　 　in high triglyceride and cholesterol subjects
５ volunteers
１２ months６ months０ months
 ２３.７ ± １.５ ２４.７ ± ２.１ ２５.２ ± ２.２BMI（kg/m２）
 ２２.６ ± ５.９ ２５.４ ± ５.５ ２５.０ ± ５.０Percentage body fat（％）
 １６０.８ ± ４２.１ １８６.８ ± ４３.９ ２０９.０ ± ４６.７TG（mg/dl）
 ２３７.５ ± １２.５* ２３８.２ ± ２７.０* ２６５.４ ± ２３.５TC（mg/dl）
 ５３.０ ± １０.５ ４８.８ ± １０.４ ５２.６ ± １０.２HDLC（mg/dl）
 １４３.５ ± ３９.１* １５２.０ ± ２５.７* １７１.０ ± ２２.７LDL（mg/dl）
 １７０.３ ± ２８.１** ３６３.０ ± １１８.４ ３２３.８ ± １０３.２VLDL（mg/dl）
 １７１.３ ± ３９.８ １４５.８ ± ２４.９ １５４.２ ± ２０.９Apo AI（mg/dl）
 １０７.５ ± ７４.６ １１８.６ ± ２３.９ １３０.２ ± １３.４Apo B（mg/dl）
 ６.４ ± １.１ ７.６ ± １.５ ７.６ ± ２.２Apo E（mg/dl）
 ２２.３ ± ７.３* ２３.２ ± ８.０* ３０.６ ± １３.５AST（IU/l）
 ２３.０ ± l４.２* ２９.２ ± １９.６* ４０.0 ± ２７.５ALT（IU/l）
 １９９.０ ± ６１.５ ２０３.２ ± ４８.９ ２１０.８ ± ６９.２ALP（IU/l）
 ７０.８ ± ８１.８ ７１.６ ± ５７.３ ９６.２ ± ９３.７γGTP（IU/l）
 ８９.７ ± ７.５ １０１.４ ± ２１.２ １００.８ ± １３.４Glucose（mg/dl）
 ５.３ ± ０.３ ５.７ ± ０.６ ５.７ ± ０.８HbA１C（％）
Values are presented as mean±SD
*p＜０.０５, **p＜０.０１ : significantly different compared to values before treatment
organ of metabolism and excretion is con-
tinuously and variedly exposed to xenobiot-
ics because of its strategic placement in the 
body.　The effect of A. formosanus on liver 
function will be further investigated.
In general A. formosanus has been used ４ 
to ４０ g of fresh weight per day, although the 
present study only used a very lower dose 
for volunteers（４５０ mg/day）.　The acute 
toxicological effects of water extracts of 
Anoectochilus species including A. formosanus 
were administered in single dose of ５,０００ 
mg/kg p.o..　No gross abnormalities were 
found in any organs of the treated animals 
at the necropsy, but the change of body 
weight of tested rats showed significant de-
crease in male and female rats at ７ and １４ 
days.　It becomes evidet that Anoectochilus 
species were non-or less toxic products.
４．Chemical composition of cultured A. ko-
shunensis
The dried whole plants cultured were ex-
tracted with MeOH at room temperature, 
and the concentrate was suspended in H２O 
and partitioned successively with CHCl３ and 
nBuOH.　The residues obtained from the 
H２O layer and the nBuOH layer were sepa-
rately  subjected  to  normal-phase  and 
reversed-phase silica gel column chromatog-
raphy to give ten compounds.　The struc-
tures  of  the  known  compounds  were 
identified as glucose, sucrose, kinsenoside
（１）,１８） ３-（R）-３- β-D-glucopyranosyloxy-４-hy-
droxybutanoic acid（２）,６，７）１-O-isopropyl- β-D-
glucopyranoside （４）,８） （R）-（ ＋ ）-３,４-dihydro-
xybutanoic acid γ-lactone（５）,１８） ４-（β-D-glu-
copyranosyloxy）benzyl alcohol（６）,１９） （６R,９
S）-９-hydroxy-megastigma-４,７-dien-３-one-９-O
- β-D-glucopyranoside（７）,２０）and corchoiono-
side C（８）,２０） by comparing their spectral 
data with those previously reported.
The positive ion FAB mass spectrum of 
unknown component, ２ showed a［M＋H］＋ 
peak at m/z ２８３ suggesting that it had the 
molecular formula C１０H１８O９.　The １３C NMR 
spectrum indicated the existence of a free 
carboxylic acid group（δ １７９.６）, an oxygen-
ated carbon at δ６６.０ and a hexose moiety at 
δ１０４.１.　The １H NMR spectrum showed 
some readily assignable signals, such as two 
methylene groups δ２.３８（１H, dd, J＝１４.８, ５.９
 Hz）, ２.４６（１H, dd, J＝１４.８, ７.３ Hz）and δ３.５９
（１H, dd, J＝１２.５, ５.９ Hz）, ３.６４（１H, dd, J＝１２.５, 
４.３ Hz）, and a methine signal ４.１２（dddd, J＝
７.３, ５.９, ５.９, ４.３ Hz）. These data suggested 
the presence of ３,４-dihydroxy butylic acid in 
２.　When ２ was exposed to mild acid condi-
tions, compound ３ was obtained.　From the 
above evidence, the structure of ２ was deter-
mined to be ３-O- β-D-glucopyranosyl-（３R）-４-
dihydroxy butanoic acid.　From these re-
sults the stereochemistry of the C３ hy-
droxyl group of ２ was confirmed to be R. 
Fig. ６ indicated the structures of compo-
nents isolated from cultured A. koshunensis.
In order to confirm the exact structure 
of  kinsenoside,  X-ray  diffraction  analysis 
of  the  corresponding  peracetate  was 
investigated.　The structure of kinsenoside
（１）, including the stereochemistry on the hy-
droxyl group at C３ was identified unambi-
guously to be ３-O- β-D-glucopyranosyl-（３R）-
４-dihydroxy  butanolide,  isolated from A. ko-
shunensis and named as kinsenoside by Ito et 
al.,１８）as indicated in Fig. ７.
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５．Antihyperliposis and hepatoprotective 
active compound, kisenoside
The crude extracts of in vitro cultured A.
koshunensis were purified guided by anti-hy-
perliposis assay using high-fat diet rats to 
isolate kinsenoside as an active component.
In an assay for anti-hyperliposis effect 
using high-fat diet rats, kinsenoside signifi-
cantly ameliorated the TG level in liver.  The 
liver and body weights were lower than 
those of control group.　Table ６ shows the 
change in body weight and liver weight 
when ６-week-old male SD rats were fed HFD
（to make hyperlipemia model rats）and the 
same diet plus oral administration of kin-
senoside［（５０ mg/kg（being equal to ３００４００ 
mg dried whole plant of A. formosanus）and １００
 mg/kg（being equal to ６００８００ mg plant）］for 
６ days, respectively.　The body weight in-
crease was seen in the normal group and con-
trol group, although no difference was 
observed between these two groups.　How-
ever, weight was suppressed in kinsenoside 
administered groups.　Especially, the １００ 
mg/kg kinsenoside administered group ex-
hibited significantly lower weight than the 
control group.
The liver weight of the control group 
was significantly higher than that of the 
normal group.　However, the liver weight of 
both the ５０ mg/kg kinsenoside group and １００
 mg/kg kinsenoside group was significantly 
lower than that of the control group.
Fig. ８ shows the value of TG in liver. 
TG, a neutral lipid, is a risk factor impli-
cated in obesity and other diseases.　The TG 
level in liver of the control group was signifi-
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Fig ６.  Structure of components isolated from Anoectochilus formosanus 
Fig ７.　X-ray analysis of peracetyl-kinsenoside
cantly  higher  than  in  the  normal  group. 
The levels in the ５０ mg/kg kinsenoside 
group and the １００ mg/kg kinsenoside group 
were significantly lower than the control 
group.　When compared to TG concentra-
tion per liver protein, the same result was 
obtained.
The  effect  of  kinsenoside  on  anti-hy-
perliposis was also examined by using 
aurothioglucose-induced  obese  mouse.２０，２１）
There was no significant difference in food 
consumption between normal and the con-
trol or kinsenoside treated groups.　This is 
in agreement with the literature.２２，２３）　Diet 
amounts during the period were ３.９３ g/d for 
the normal mouse, ４.１８ g/d for the control 
mouse, ４.２３ g/d and ４.０９ g/d for kinsenoside 
treated mouse.　Fig. ９ shows the change in 
body weight for normal mice, and when 
aurothioglucose-induced obese mice that 
were fed the HFD（as control）or the same 
diet containing ０.１％ or ０.２％ kinsenoside for 
６ weeks, respectively.　Rapid weight in-
crease was observed in the control group, 
while it was suppressed in the kinsenoside 
treated groups.　Especially, the ０.２％ kin-
senoside administered group exhibited sig-
nificantly lower weight than the control 
group.　The weight increases of liver and 
uterine fat-pads were also observed in the 
control group, while in the kinsenoside 
treated groups, they were significantly de-
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Table 6.　Hepatoprotective activity of kinsenoside on the body
　　　　　                 and liver weight in rats
Liver weight（g）Body weight（g）Dose（p.o.）（mg/kg）Group
 ６.８０ ± ０.１８ ２１２.３２ ± ２.２４―Normal
Control
Kinsenoside
Kinsenoside
 ８.８１ ± ０.３１## ２１３.１９ ± ４.２３―
 ７.７２ ± ０.１８** ２０４.１０ ± １.９７ ５０
 ７.０８ ± ０.２８** ２０２.１８ ± ２.３９*１００
## p＜０.０１ versus normal group ; *p＜０.０５, **p＜０.０１ versus control group
##p＜０.０１ significantly different from the normal 
group; **p＜０.０１ significantly different from the 
control group
*p＜０.１ significantly different from the control 
group
Fig ８.　Effect of kinsenoside on triglyceride 
level in liver of rats
##p＜0.01 significantly different from the normal 
group; **p＜0.01 significantly different from the 
control group
Fig ９.　Effect of kinsenoside on the triglyceride 
level in liver after aurothioglucose-in-
duced obese mice after 6 weeks
creased（Fig. １０）.　The livers in the control 
group were considerably swollen, and the 
color and luster were those of fatty liver. 
These phenomena were not observed in the 
kinsenoside treated groups.
Fig. １１ shows the typical histological 
views of the liver in the mice being fed the 
HFD and the diet with kinsenoside（０.１％ and 
０.２％ , respectively）after ６ weeks.　A great 
deal of accumulated fatty drops was ob-
served in the control group, while it was sig-
nificantly decreased in the kinsenoside 
administered groups.　It is considered that 
the body weight increase was suppressed by 
the improvement of lipid-metabolism.
The findings of the present study indi-
cate kinsenoside may be useful for the treat-
ment for hyperliposis.　In aurothioglucose-
induced obese mouse, kinsenoside suppressed 
the body and liver weight increase, signifi-
cantly ameliorated the triglyceride level in 
the liver, and also reduced the deposition of 
uterine fat-pads.
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